1.888.321.7828 sales@pepid.com

Founder and CEO, Mark Rosenbloom, MD, MBA joins PEPID Pulse’s Implementing Precision Medicine live broadcast series at HIMSS 2019. Dr. Rosenbloom’s talk, “Implementing Precision Medicine in the Clinical Setting: Challenges and Rewards” expounds on:

  1. Pharmacogenomics’ present utilization and projected growth,
  2. The short- and long-term challenges and merits of PGx adoption, and
  3. How actionable point-of-care resources such as PEPID’s PGx can significantly improve clinician workflow while improving patient outcomes.

Check back soon for a detailed transcription of this broadcast.




For 25 years, PEPID has been a leading global developer of clinical and drug information resources and mobile applications for healthcare providers and institutions. Their trusted, validated content and intuitive workflow provide clinicians peer-reviewed support for diagnosis and treatment at the patient-point-of-care. It’s accessed individually or integrated into any healthcare system.

To find out more, go to www.pepid.com


Questions or comments, e-mail Anna Tan at press@pepid.com.